Company Encyclopedia
View More
name
ZJJF
600668.SH
Zhejiang Jianfeng Group Co., Ltd. engages in the building materials and medicine business in China. It provides pharmaceutical products, hazardous chemicals, and pharmaceutical excipients and packaging materials, as well as pesticides and pharmaceutical chemical intermediates. The company also offers cement, cement products, building materials, crushed stones, woven bags, ordinary Portland, clinker and commercial concrete, limestone, artificial sand, and aggregates, as well as non-metallic mineral products.
43.39 B
600668.SHMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Industrial ConglomeratesIndustry
Industry Ranking2/4
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE12.69%B
    • Profit Margin24.77%A
    • Gross Margin19.54%D
  • Growth ScoreC
    • Revenue YoY-2.68%D
    • Net Profit YoY1814.79%A
    • Total Assets YoY14.96%A
    • Net Assets YoY13.59%B
  • Cash ScoreC
    • Cash Flow Margin403.77%C
    • OCF YoY-2.68%D
  • Operating ScoreC
    • Turnover0.36C
  • Debt ScoreB
    • Gearing Ratio24.60%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    ZJJF: Has cumulatively spent CNY 10.3103 million to repurchase 0.211% of shares

    ZJJF announced that as of October 31, the company has repurchased 871,800 shares, accounting for 0.211% of the total share capital, with a cumulative expenditure of 10.3103 million yuan. The repurchase plan was approved on April 18, 2025, with an expected repurchase amount of 20 million to 40 million yuan, mainly for employee stock ownership plans or equity incentives. The repurchase price range is 11.63 yuan/share to 12.27 yuan/share

    Zhitong·
    SH
    600668
    +0.61%
    Zhitong·
    SH
    600668
    +0.61%

    ZJJF plans to repurchase shares worth 20 million to 40 million yuan for incentives

    The board of directors of ZJJF has approved a share repurchase plan, intending to repurchase shares for between 20 million and 40 million yuan, with a repurchase price not exceeding 12.42 yuan per share, primarily for employee stock ownership plans or equity incentives. It is expected to repurchase between 1.6103 million and 3.2206 million shares, accounting for 0.39%-0.78% of the total share capital. The implementation period is 12 months, and the repurchase will not have a significant impact on the company's operations and finances, but there are risks of the stock price exceeding the range and funds not being in place

    Zhitong·
    SH
    600668
    +0.61%
    Zhitong·
    SH
    600668
    +0.61%

    ZJJF: Obtained a commitment letter for a special loan for stock repurchase from financial institutions not exceeding 36 million yuan

    ZJJF announced that it recently obtained a "Loan Commitment Letter" issued by the Jinhua Branch of China Merchants Bank Co., Ltd., with the main content as follows: the loan amount shall not exceed RMB 36 million, the loan interest rate is 1.8%, the loan term shall not exceed 36 months, and the loan purpose is specifically for repurchasing shares of Zhejiang ZJJF Co., Ltd. The specific loan matters for this stock repurchase shall be subject to the formal loan contract signed by both parties

    Zhitong·
    SH
    600668
    +0.61%
    Zhitong·
    SH
    600668
    +0.61%

    ZJJF: Net profit of 618 million yuan in the first half of 2025, a year-on-year increase of 1,196.93%

    ZJJF announced that in the first half of 2025, operating revenue was 1.299 billion yuan, a year-on-year decrease of 4.42%. Net profit was 618 million yuan, a year-on-year increase of 1,196.93%. Basic earnings per share were 1.74 yuan/share, a year-on-year increase of 1,153.76%

    Zhitong·
    SH
    600668
    +0.61%
    Zhitong·
    SH
    600668
    +0.61%

    ZJJF's subsidiary has obtained the approval notice for the listing application of fumaric acid vorinostat chemical raw materials

    ZJJF's subsidiary Anhui Jianfeng Beika Pharmaceutical Co., Ltd. recently received the notice of approval for the marketing application of the chemical raw material drug Fumaric Acid Vorinostat from the National Medical Products Administration. This drug is used to treat reflux esophagitis and meets the relevant national review technical standards, marking its availability for sale in the domestic market and aiding the subsidiary's business expansion

    Zhitong·
    SH
    600668
    +0.61%
    Zhitong·
    SH
    600668
    +0.61%
    © 2025 Longbridge｜Disclaimer